Published in Int J Chron Obstruct Pulmon Dis on March 31, 2017
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2012) 22.96
ROCR: visualizing classifier performance in R. Bioinformatics (2005) 19.60
Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J (2006) 6.34
Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) Am J Respir Crit Care Med (1996) 5.82
Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med (2011) 3.58
Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA (1995) 3.45
In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med (2003) 2.64
Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem (2005) 2.10
Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology. Eur Respir J (2011) 1.81
Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD. Chest (2007) 1.64
Factors affecting survival of hospitalised patients with COPD. Eur Respir J (2005) 1.60
Predictors of outcome for patients with COPD requiring invasive mechanical ventilation. Chest (2001) 1.50
Midregional proatrial natriuretic peptide predicts survival in exacerbations of COPD. Chest (2010) 1.43
Identification of an Adrenomedullin precursor fragment in plasma of sepsis patients. Peptides (2004) 1.32
Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. Chest (2015) 1.25
Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. Am J Respir Crit Care Med (2014) 1.20
Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD. Chest (2008) 1.20
Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue. Endocrinology (2005) 1.19
Predictors of outcomes in COPD exacerbation cases presenting to the emergency department. Eur Respir J (2008) 1.15
Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD. Chest (2008) 1.00
C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations. Curr Opin Pulm Med (2009) 0.99
Biomarkers from distinct biological pathways improve early risk stratification in medical emergency patients: the multinational, prospective, observational TRIAGE study. Crit Care (2015) 0.97
Chronic obstructive pulmonary disease exacerbations in emergency departments: predictors of outcome. Curr Opin Pulm Med (2010) 0.88
A clinical in-hospital prognostic score for acute exacerbations of COPD. Respir Res (2014) 0.85
The prognostic blood biomarker proadrenomedullin for outcome prediction in patients with chronic obstructive pulmonary disease (COPD): a qualitative clinical review. Clin Chem Lab Med (2015) 0.85
The value of assessment tests in patients with acute exacerbation of chronic obstructive pulmonary disease. Am J Med Sci (2014) 0.82
Stable state MR-proadrenomedullin level is a strong predictor for mortality in COPD patients. Chest (2013) 0.79
Diagnostic and prognostic value of plasma adrenomedullin in COPD exacerbation. Respir Care (2014) 0.78
Adrenomedullin optimises mortality prediction in COPD patients. Respir Med (2015) 0.77
Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD. Thorax (2016) 0.77
Prognostic value of PCT, copeptin, MR-proADM, MR-proANP and CT-proET-1 for severe acute dyspnea in the emergency department: the BIODINER study. Biomarkers (2016) 0.77